CASI Pharmaceuticals Balance Sheet (2021-2025) | CASI

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Dec2021	Mar2022	Dec2022	Jun2023	Dec2023	Mar2024	Jun2024	Dec2024	Mar2025	Jun2025
Assets
Current Assets
Cash & Equivalents	0.04B		0.05B	0.00B	0.02B	0.01B	0.00B	0.01B	0.00B	0.01B
Short-term Investments	0.01B		0.00B	19.85B	0.01B
Cash & Current Investments	0.05B		0.05B	19.85B	0.03B	0.01B	0.00B	0.01B	0.00B	0.01B
Receivables - Net	0.01B		0.01B	12.53B	9.55B	0.01B	6.78B	0.02B	7.60B	0.01B
Receivables - Other					0.59B	0.00B
Receivables	0.01B		0.01B	12.53B	10.14B	0.01B	6.78B	0.02B	7.60B	0.01B
Inventory	0.00B		0.01B	7.77B	15.88B	0.02B	14.61B	0.01B	4.15B	0.00B
Prepaid Assets	0.00B		0.00B	1.91B	2.56B	0.00B	2.11B	0.00B	2.71B	0.00B
Current Assets	0.06B		0.07B	61.00B	59.34B	0.04B	37.20B	0.04B	27.16B	0.02B
Non-Current Assets
Construction in Progress	0.01B		0.01B		0.00B
Property, Plant & Equipment (Net)	0.01B		0.01B	10.12B	9.24B	0.01B	8.50B	0.01B	7.66B	0.01B
Long-Term Investments	0.04B		0.00B	3.64B	1.69B	0.00B	1.77B	0.00B	1.91B	0.00B
Intangibles	0.02B		0.00B	0.54B	1.84B	0.00B	1.36B	0.00B	0.23B	0.00B
Goodwill & Intangibles	0.02B		0.00B	0.54B	1.84B	0.00B	1.36B	0.00B	0.23B	0.00B
Other Non-Current Assets	0.00B		0.00B	1.21B	0.77B	0.00B	0.69B	0.00B	0.59B	0.00B
Non-Current Assets	0.08B		0.02B	-61.00B	-59.27B	0.01B	-37.20B	0.01B	-27.16B	0.01B
Assets	0.14B		0.10B	0.00B	0.08B	0.06B	0.00B	0.05B	0.00B	0.03B
Liabilities
Current Liabilities
Accounts Payables	0.01B		0.01B		0.01B			0.02B
Payables	0.01B		0.01B		0.01B			0.02B
Accumulated Expenses			0.01B	9.53B	12.29B	0.01B	8.79B	0.02B	14.03B	0.02B
Other Accumulated Expenses	0.00B		0.00B		0.00B			0.00B
Short term Debt								0.02B
Current Leases	0.00B		0.00B		0.00B			0.00B
Current Taxes	0.00B		0.00B		0.00B
Current Deferred Revenue	0.00B
Total Current Liabilities	0.01B		0.02B	11.91B	16.73B	0.01B	9.58B	0.04B	33.71B	0.04B
Non-Current Liabilities
Non-Current Debt	0.01B		0.01B		18.89B	0.02B	18.46B
Minority Interest	0.02B		0.02B
Operating Leases	0.00B		0.00B		0.00B			0.00B
Other Non-Current Liabilities	0.01B		0.01B	12.12B	15.48B	0.02B	14.20B	0.02B	15.18B	0.01B
Total Non-Current Liabilities	0.02B		0.02B	-12.12B	-15.43B	0.03B	-14.20B	0.04B	-15.18B	0.04B
Total Liabilities	0.03B		0.03B	0.00B	0.05B	0.04B	0.00B	0.05B	0.00B	0.05B
Shareholder's Equity
Total Debt	0.01B		0.01B		18.89B	0.02B	18.46B	0.02B
Common Equity	0.08B		0.04B		24.16B	0.02B	9.02B	0.00B	-8.07B	-0.02B
Shareholder's Equity	0.08B		0.04B	32.23B	0.02B			0.00B
Liabilities and Shareholders Equity	0.14B		0.10B	0.00B	0.08B	0.06B	0.00B	0.05B	0.00B	0.03B
Treasury Shares	0.00B	0.00B			0.00B			0.00B
Retained Earnings	-0.61B		-0.64B	-651.80B	-660.82B	-0.67B	-677.31B	-0.70B	-710.83B	-0.72B

Research Tools

CASI Pharmaceuticals Balance Sheet (2021-2025) | CASI

Create an account

Sign In

Reset Password